In the article titled “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV” [1], there was an error in the Discussion section, where “Our systematic review highlights that, for precancerous lesions (CIN), the only available proxy of cervical cancer and heterogeneity among pooled studies is substantial” should be changed to “Our systematic review highlights that, for precancerous lesions (CIN), the only available proxy of cervical cancer, heterogeneity among pooled studies is substantial.” In addition, there was an error in Table 3. The corrected table is as follows.
Corrigendum | Open Access
Corrigendum to “Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV”
Received05 Apr 2017
Accepted10 Apr 2017
Published30 May 2017
References
S. Di Mario, V. Basevi, P. L. Lopalco, S. Balduzzi, R. D’Amico, and N. Magrini, “Are the two human papillomavirus vaccines really similar? A systematic review of available evidence: efficacy of the two vaccines against HPV,” Journal of Immunology Research, vol. 2015, Article ID 435141, 13 pages, 2015.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2017 Simona Di Mario et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.